DE3579143D1 - Allylamine. - Google Patents

Allylamine.

Info

Publication number
DE3579143D1
DE3579143D1 DE8585116657T DE3579143T DE3579143D1 DE 3579143 D1 DE3579143 D1 DE 3579143D1 DE 8585116657 T DE8585116657 T DE 8585116657T DE 3579143 T DE3579143 T DE 3579143T DE 3579143 D1 DE3579143 D1 DE 3579143D1
Authority
DE
Germany
Prior art keywords
allylamine
beta
methylenefuranethanamines
relates
antihypertensive agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585116657T
Other languages
English (en)
Inventor
Thomas M Bargar
Broersma, Jr
James R Mccarthy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3579143D1 publication Critical patent/DE3579143D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/36Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Lubricants (AREA)
  • Paper (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
DE8585116657T 1984-12-31 1985-12-30 Allylamine. Expired - Fee Related DE3579143D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68762784A 1984-12-31 1984-12-31

Publications (1)

Publication Number Publication Date
DE3579143D1 true DE3579143D1 (en) 1990-09-13

Family

ID=24761163

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585116657T Expired - Fee Related DE3579143D1 (en) 1984-12-31 1985-12-30 Allylamine.

Country Status (19)

Country Link
EP (1) EP0186915B1 (de)
JP (1) JPS61161275A (de)
KR (1) KR900003398B1 (de)
CN (1) CN1007247B (de)
AT (1) ATE55379T1 (de)
AU (1) AU585922B2 (de)
CA (1) CA1245228A (de)
DE (1) DE3579143D1 (de)
DK (1) DK163665C (de)
ES (1) ES8701744A1 (de)
FI (1) FI84822C (de)
GR (1) GR853147B (de)
HU (1) HU193620B (de)
IE (1) IE58188B1 (de)
NO (1) NO168580C (de)
NZ (1) NZ214697A (de)
PH (1) PH21981A (de)
PT (1) PT81771B (de)
ZA (1) ZA859890B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293511C (en) * 1986-12-23 1991-12-24 James R. Mccarthy Allenyl amines
US4847288A (en) * 1986-12-23 1989-07-11 Merrell Dow Pharmaceuticals Inc. Allenyl amines
NZ223583A (en) * 1987-02-26 1990-02-26 Merrell Dow Pharma 2- or 3-thienyl-or-furyl-2-propyn-1-amines and antihypertensive compositions
CN112441934B (zh) * 2020-11-25 2022-04-22 华南理工大学 一种卤代氧杂烯丙基胺类化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454158A (en) * 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors
NZ223583A (en) * 1987-02-26 1990-02-26 Merrell Dow Pharma 2- or 3-thienyl-or-furyl-2-propyn-1-amines and antihypertensive compositions

Also Published As

Publication number Publication date
PT81771B (pt) 1987-11-11
CN85109441A (zh) 1986-08-13
DK607685D0 (da) 1985-12-30
EP0186915A2 (de) 1986-07-09
AU5172685A (en) 1986-07-10
CA1245228A (en) 1988-11-22
FI855159A (fi) 1986-07-01
DK163665C (da) 1992-09-07
PH21981A (en) 1988-05-02
CN1007247B (zh) 1990-03-21
FI84822B (fi) 1991-10-15
AU585922B2 (en) 1989-06-29
NO168580B (no) 1991-12-02
FI855159A0 (fi) 1985-12-27
NO855352L (no) 1986-07-01
HU193620B (en) 1987-11-30
IE58188B1 (en) 1993-07-28
KR900003398B1 (ko) 1990-05-18
NZ214697A (en) 1988-10-28
KR860004852A (ko) 1986-07-14
ATE55379T1 (de) 1990-08-15
IE853327L (en) 1986-06-30
EP0186915A3 (en) 1987-03-25
DK607685A (da) 1986-07-01
ZA859890B (en) 1987-06-24
EP0186915B1 (de) 1990-08-08
PT81771A (en) 1986-01-02
JPS61161275A (ja) 1986-07-21
GR853147B (de) 1986-04-29
ES8701744A1 (es) 1986-12-01
ES550569A0 (es) 1986-12-01
FI84822C (fi) 1992-01-27
HUT40093A (en) 1986-11-28
NO168580C (no) 1992-03-11
DK163665B (da) 1992-03-23

Similar Documents

Publication Publication Date Title
ES2065881T3 (es) Nuevos inhibidores de dopamina beta-hidroxilasa.
GR79463B (de)
DE3579143D1 (en) Allylamine.
ES8703866A1 (es) Un procedimiento para preparar una amina alilica
GR3003547T3 (de)
ES8504799A1 (es) Procedimiento de obtencion de piridopirimidinonas
ATE75478T1 (de) Gametozide.
FR2396011A1 (fr) Nouvelles 2,3-dihydro-1,4-benzoxathines pour inhibition de lipogenese

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee